Literature DB >> 29232302

Minimally Invasive Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy.

Farah N Musharbash1, Matthew R Schill, Matthew C Henn, Ralph J Damiano.   

Abstract

Surgical septal myectomy is the treatment of choice for patients with symptomatic hypertrophic obstructive cardiomyopathy refractory to medications. This report describes our minimally invasive approach for performing a septal myectomy via a ministernotomy that has been used at our institution for more than a decade. In particular, patient preparation, surgical technique, and clinical considerations are highlighted. Performed properly, this minimally invasive technique is a feasible and effective approach in our experience.

Entities:  

Mesh:

Year:  2017        PMID: 29232302      PMCID: PMC5774662          DOI: 10.1097/IMI.0000000000000421

Source DB:  PubMed          Journal:  Innovations (Phila)        ISSN: 1556-9845


  6 in total

1.  Robot-assisted septal myectomy for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction.

Authors:  Zain Khalpey; Lev Korovin; W Randolph Chitwood; Robert Poston
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-02       Impact factor: 5.209

2.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Steve R Ommen; Barry J Maron; Iacopo Olivotto; Martin S Maron; Franco Cecchi; Sandro Betocchi; Bernard J Gersh; Michael J Ackerman; Robert B McCully; Joseph A Dearani; Hartzell V Schaff; Gordon K Danielson; A Jamil Tajik; Rick A Nishimura
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

3.  Minimally invasive septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy and intrinsic mitral valve disease.

Authors:  Daniyar Sh Gilmanov; Stefano Bevilacqua; Marco Solinas; Matteo Ferrarini; Enkel Kallushi; Philippo Santarelli; Pier Andrea Farneti; Mattia Glauber
Journal:  Innovations (Phila)       Date:  2015 Mar-Apr

Review 4.  Limited versus full sternotomy for aortic valve replacement.

Authors:  Bilal H Kirmani; Sion G Jones; S C Malaisrie; Darryl A Chung; Richard Jnn Williams
Journal:  Cochrane Database Syst Rev       Date:  2017-04-10

5.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

6.  A Novel Minimally Invasive Approach for Surgical Septal Myectomy.

Authors:  Amine Mazine; Aly Ghoneim; Ismail Bouhout; William Fortin; Ilyes Berania; Philippe L L'Allier; Patrick Garceau; Denis Bouchard
Journal:  Can J Cardiol       Date:  2016-04-07       Impact factor: 5.223

  6 in total
  1 in total

1.  Minimally Invasive Versus Full-Sternotomy Septal Myectomy for Hypertrophic Cardiomyopathy.

Authors:  Farah N Musharbash; Matthew R Schill; Vivek H Hansalia; Richard B Schuessler; Jeremy E Leidenfrost; Spencer J Melby; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2018 Jul/Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.